Guías Docentes Electrónicas
1. General information
Course:
PHARMACEUTICAL TECHNOLOGY II
Code:
14330
Type:
CORE COURSE
ECTS credits:
6
Degree:
376 - UNDERGRADUATE DEGREE PROGRAMME IN PHARMACY
Academic year:
2022-23
Center:
14 - FACULTY OF PHARMACY
Group(s):
10 
Year:
4
Duration:
First semester
Main language:
Spanish
Second language:
English
Use of additional languages:
English Friendly:
Y
Web site:
Bilingual:
N
Lecturer: MARIA FRANCISCA GALINDO ANAYA - Group(s): 10 
Building/Office
Department
Phone number
Email
Office hours
Facultad de Farmacia 2.17
CIENCIAS MÉDICAS
967599200
maria.galindo@uclm.es

Lecturer: JOAQUIN GONZALEZ FUENTES - Group(s): 10 
Building/Office
Department
Phone number
Email
Office hours
Facultad de Farmacia AB. Despecho 3.8
CIENCIAS MÉDICAS
2236
joaquin.gfuentes@uclm.es

Lecturer: MARIA VICTORIA LOZANO LOPEZ - Group(s): 10 
Building/Office
Department
Phone number
Email
Office hours
Facultad Farmacia. 2.4
CIENCIAS MÉDICAS
8238
mvictoria.lozano@uclm.es

2. Pre-Requisites
Not established
3. Justification in the curriculum, relation to other subjects and to the profession
Not established
4. Degree competences achieved in this course
Course competences
Code Description
B01 Proficiency in a second foreign language at level B1 of the Common European Framework of Reference for Languages.
B02 Knowledge of Information and Communication Technologies (ICT).
B03 A correct oral and written communication
B04 Ethical commitment and professional deontology.
B05 Ability to develop those learning skills necessary to undertake further studies.
EFT01 Using statistical analysis applied to pharmaceutical sciences
EFT02 Apply both computational and data processing techniques, for getting information about physical, chemical and biological data
EFT05 Using statistical analysis applied to pharmaceutical sciences
EFT06 Design, optimize and elaborate the pharmaceutical forms guaranteeing their quality, including the formulation and quality control of medicines, the development of master formulas and officinal preparations.
EFT07 Able to apply the quality control process to medical devices, dermopharmaceutical and cosmetic products and package materials.
G01 Identify, design, obtain, analyze, control and produce drugs and medicines, as well as other products and raw materials of sanitary interest for human or veterinary use.
G04 Design, prepare, supply and dispense medicines and other products of health interest.
G13 Develop communication and information skills, both oral and written, to deal with patients and users of the centre where they carry out their professional activity. Promote the capacity to work and collaborate with multidisciplinary teams and those related to other health professionals.
G15 Recognise own limitations and the need to maintain and update professional competence, with particular emphasis on self-learning of new knowledge based on scientific evidence.
T01 Critical thinking skills based on the application of the scientific method
T02 Ability to manage quality scientific information, bibliography, specialized databases and resources accessible through the Internet.
T03 Handling of basic and specific software for the treatment of information and experimental results.
T04 Motivation for quality, safety at work and awareness of environmental issues, with knowledge of the internationally recognised systems for the correct management of these aspects.
T05 Organizational, planning and implementation skills.
T06 Ability to address human resources decision-making and management.
T07 Ability to work as a team and, where appropriate, exercise leadership functions, encouraging entrepreneurship.
T08 Develop interpersonal skills and the ability to function in an international and multicultural context.
5. Objectives or Learning Outcomes
Course learning outcomes
Description
To know the controls in raw materials, semi-finished and finished products, as well as the validation of processes in order to ensure the quality of the medicines manufactured.
Understanding the checks necessary to ensure the quality of pharmaceutics skin products, sanitary products, and cosmetics.
Know the vehiculizacion nanoparticles as forms of drugs.
Ability to select the route of administration and the pharmaceutical form.
Ability to work under standards of good laboratory practice (GLP).
Ability to plan, design and develop preformulation studies of the different pharmaceutical forms and to interpret the results.
Know and understand the fundamentals of the Pharmaceutical Technology
Develop drugs regarding its qualitative and quantitative composition and select the optimal technological processes to be used in its manufacture.
Additional outcomes
Not established.
6. Units / Contents
  • Unit 1:
    • Unit 1.1:
    • Unit 1.2:
  • Unit 2:
    • Unit 2.1:
    • Unit 2.2:
  • Unit 3:
    • Unit 3.1:
  • Unit 4:
    • Unit 4.1:
    • Unit 4.2:
    • Unit 4.3:
    • Unit 4.4:
    • Unit 4.5:
  • Unit 5:
    • Unit 5.1:
    • Unit 5.2:
    • Unit 5.3:
    • Unit 5.4:
    • Unit 5.5:
  • Unit 6:
    • Unit 6.1:
    • Unit 6.2:
    • Unit 6.3:
    • Unit 6.4:
    • Unit 6.5:
    • Unit 6.6:
7. Activities, Units/Modules and Methodology
Training Activity Methodology Related Competences (only degrees before RD 822/2021) ECTS Hours As Com Description
Class Attendance (theory) [ON-SITE] Combination of methods B01 B02 B03 B04 B05 EFT01 EFT02 EFT05 EFT06 EFT07 G01 G04 G13 G15 T01 T02 T03 T04 T05 T06 T07 T08 1.44 36 Y N
Class Attendance (practical) [ON-SITE] Practical or hands-on activities B01 B02 B03 B04 B05 EFT01 EFT02 EFT05 EFT06 EFT07 G01 G04 G13 G15 T01 T02 T03 T04 T05 T06 T07 T08 0.8 20 Y Y
Formative Assessment [ON-SITE] Assessment tests B01 B02 B03 B04 B05 EFT01 EFT02 EFT05 EFT06 EFT07 G01 G04 G13 G15 T01 T02 T03 T04 T05 T06 T07 T08 0.16 4 Y Y
Study and Exam Preparation [OFF-SITE] Self-study B01 B02 B03 B04 B05 EFT01 EFT02 EFT05 EFT06 EFT07 G01 G04 G13 G15 T01 T02 T03 T04 T05 T06 T07 T08 3.6 90 Y N
Total: 6 150
Total credits of in-class work: 2.4 Total class time hours: 60
Total credits of out of class work: 3.6 Total hours of out of class work: 90

As: Assessable training activity
Com: Training activity of compulsory overcoming (It will be essential to overcome both continuous and non-continuous assessment).

8. Evaluation criteria and Grading System
Evaluation System Continuous assessment Non-continuous evaluation * Description
Test 70.00% 70.00%
Laboratory sessions 20.00% 20.00%
Assessment of active participation 10.00% 10.00%
Total: 100.00% 100.00%  
According to art. 4 of the UCLM Student Evaluation Regulations, it must be provided to students who cannot regularly attend face-to-face training activities the passing of the subject, having the right (art. 12.2) to be globally graded, in 2 annual calls per subject , an ordinary and an extraordinary one (evaluating 100% of the competences).

Evaluation criteria for the final exam:
  • Continuous assessment:
    Evaluation criteria not defined
  • Non-continuous evaluation:
    Evaluation criteria not defined

Specifications for the resit/retake exam:
Evaluation criteria not defined
Specifications for the second resit / retake exam:
Evaluation criteria not defined
9. Assignments, course calendar and important dates
Not related to the syllabus/contents
Hours hours
Class Attendance (theory) [PRESENCIAL][Combination of methods] 36
Class Attendance (practical) [PRESENCIAL][Practical or hands-on activities] 20
Formative Assessment [PRESENCIAL][Assessment tests] 4
Study and Exam Preparation [AUTÓNOMA][Self-study] 90

Global activity
Activities hours
10. Bibliography and Sources
Author(s) Title Book/Journal Citv Publishing house ISBN Year Description Link Catálogo biblioteca
Agencia Europea del Medicamento http://emea.europa.eu  
 
The Internet Drug Index http://www.rxlist.com/script/main/hp.asp  
Real Farmacopea Española. 5ª Edición. Ministerio de Sanidad, Servicios Sociales e Igualdad. Madrid 2015 http://biblioteca.uclm.es/  
Portal farmacéutico. Bases de datos del CGCOT (BOT) https://botplusweb.portalfarma.com/  
Medscape DrugInfo http://search.medscape.com/reference-search  
FDA http://www.fda.gov/  
Allen L.V. The art, science and technology of pharmaceutical compounding Ed American Pharmaceutical Association, Washington 2004  
Alonso M.J., Csaba N. Nanostructured Biomaterials for Overcoming Biological Barriers RSC Publishing 978-1-84973-363-2 2012 Ficha de la biblioteca
Aulton M.E La ciencia del diseño de las formas de dosificación. Elsevier D.L. 2004  
Faulí y Trillo C. Tratado de Farmacia Galénica Luzán 5, S.A. de Ediciones. Madrid 1993  
Florence, A. T. (Alexander Taylor) Physicochemical principles of pharmacy Pharmaceutical Press 978-0-85369-984-2 2011 Ficha de la biblioteca
Isabel González Álvarez, Miguel Ángel Cabrera Pérez, Maria del Val Bermejo Sanz Metodologías Biofarmacéuticas en el Desarrollo de Medicamentos Universitas Miguel Hernández 978-84-16024-16-2 2015  
Martin A. Physical Pharmacy: Physical chemical principles in the Pharmaceutical Sciences Lea & Febiger, Philadelphia 1993  
Martínez Pacheco R. Tratado de Tecnología Farmacéutica. Volumen III "Formas de dosificación" Síntesis 9788490771037 2017  
Martínez Pacheco R. Tratado de Tecnología Farmacéutica. Volumen II "Operaciones básicas" Síntesis 9788490771020 2016  
Martínez Pacheco R. Tratado de Tecnología Farmacéutica. Volumen I "Sistemas farmacéuticos" Síntesis 9788490770986 2016  
Rowe R.C. Handbook of pharmaceutical excipients 5ª Edición. Pharmaceutical Press and the American Pharmacists Association 2005  
Torres Suarez A. Estabilidad de medicamentos. Asociación Española de Farmacéuticos de la Industria (AEFI). Madrid 2004  
Uchegbu I.F., Schatzlein A. Polymers in drug delivery CRC/Taylor & Francis 978-0-8493-2533-5 2006 Ficha de la biblioteca
Vila Jato J.L. Tecnología Farmacéutica II: Formas farmacéuticas Editorial Síntesis D.L. 2001  
Vila Jato J.L. Tecnología Farmacéutica I: Aspectos fundamentales de los sistemas farmacéuticos y operaciones básicas Editorial Síntesis D.L. 2001  



Web mantenido y actualizado por el Servicio de informática